financetom
Business
financetom
/
Business
/
Target Unusual Options Activity For March 25
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Target Unusual Options Activity For March 25
Mar 25, 2024 1:33 PM

Whales with a lot of money to spend have taken a noticeably bearish stance on Target ( TGT ).

Looking at options history for Target ( TGT ) we detected 15 trades.

If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 60% with bearish.

From the overall spotted trades, 2 are puts, for a total amount of $73,912 and 13, calls, for a total amount of $509,290.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $140.0 to $180.0 for Target ( TGT ) over the last 3 months.

Analyzing Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Target's ( TGT ) options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Target's ( TGT ) substantial trades, within a strike price spectrum from $140.0 to $180.0 over the preceding 30 days.

Target Option Volume And Open Interest Over Last 30 Days

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
TGT CALL SWEEP BEARISH 10/18/24 $170.00 $57.4K 54 36
TGT CALL SWEEP BEARISH 01/17/25 $150.00 $51.9K 2.4K 100
TGT PUT SWEEP BULLISH 06/21/24 $155.00 $48.2K 1.2K 265
TGT CALL TRADE BEARISH 01/17/25 $165.00 $44.1K 992 64
TGT CALL TRADE BEARISH 01/17/25 $165.00 $44.1K 992 45

About Target

Target ( TGT ) serves as the nation's sixth-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's ( TGT ) upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a top U.S. retailer.Today, Target ( TGT ) operates over 1,900 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast physical footprint is typically concentrated in urban and suburban markets as the firm seeks to attract a more affluent consumer base.

Where Is Target Standing Right Now?

Currently trading with a volume of 2,968,312, the TGT's price is up by 0.81%, now at $170.0.

RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

Anticipated earnings release is in 51 days.

What The Experts Say On Target

In the last month, 5 experts released ratings on this stock with an average target price of $191.2.

Maintaining their stance, an analyst from Guggenheim continues to hold a Buy rating for Target ( TGT ), targeting a price of $190.

Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Target ( TGT ), targeting a price of $195.

An analyst from RBC Capital persists with their Outperform rating on Target ( TGT ), maintaining a target price of $191.

An analyst from Citigroup has decided to maintain their Neutral rating on Target ( TGT ), which currently sits at a price target of $180.

An analyst from Argus Research has decided to maintain their Buy rating on Target ( TGT ), which currently sits at a price target of $200.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Target ( TGT ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Nippon Steel Hires Ex-Secretary of State Pompeo to Help Close US Steel Purchase, Bloomberg Reports
--Nippon Steel Hires Ex-Secretary of State Pompeo to Help Close US Steel Purchase, Bloomberg Reports
Jul 19, 2024
02:35 PM EDT, 07/19/2024 (MT Newswires) -- Price: 38.16, Change: +0.32, Percent Change: +0.85 ...
Oracle Settles Privacy Lawsuit for $115 Million
Oracle Settles Privacy Lawsuit for $115 Million
Jul 19, 2024
02:40 PM EDT, 07/19/2024 (MT Newswires) -- Oracle (ORCL) ) agreed to pay $115 million to settle a lawsuit accusing it of violating California's privacy laws by collecting and selling personal information without consent. The preliminary settlement, filed Thursday night in a federal court in San Francisco, still requires court approval. The plaintiffs claimed Oracle created unauthorized digital dossiers containing...
Richards Packaging Income Fund Announced July 2024 Distribution
Richards Packaging Income Fund Announced July 2024 Distribution
Jul 19, 2024
02:40 PM EDT, 07/19/2024 (MT Newswires) -- Richards Packaging Income Fund (RPI-UN.TO) announced Friday its cash distribution for the month ended July 31, 2024 of $0.11 per unit. This distribution will be to unitholders of record at the close of business on July 31, 2024 and will be payable on August 14, 2024, and is consistent with June's cash distribution....
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today?
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today?
Jul 19, 2024
60 Degrees Pharmaceuticals Inc. ( SXTP ) shares are surging on Friday following the company’s announcement of clinical trial agreements for their Tafenoquine Babesiosis study. What Happened: The company has signed clinical trial agreements with Yale University, Rhode Island Hospital and Tufts Medical Center. This marks the world’s first randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved